Literature DB >> 17065339

Interactions between delivery, transport, and phosphorylation of glucose in governing uptake into human skeletal muscle.

Alessandra Bertoldo1, R Richard Pencek, Koichiro Azuma, Julie C Price, Carol Kelley, Claudio Cobelli, David E Kelley.   

Abstract

Skeletal muscle accounts for a large proportion of insulin-stimulated glucose utilization. It is generally regarded that much of the control over rates of uptake is posited within the proximal steps of delivery, transport, and phosphorylation of glucose, with glucose transport as the main locus of control. Whether insulin modulates the distribution of control across these steps and in what manner remains uncertain. The current study addressed this in vivo using dynamic positron emission tomography (PET) imaging of human muscle with sequential injections of three tracers ([(15)O]H(2)O, [(11)C]3-O-methyl glucose [3-OMG], and [(18)F]fluoro-deoxy glucose [FDG]) that enabled quantitative determinations of glucose delivery, transport, and its phosphorylation, respectively. Lean, healthy, research volunteers were studied during fasting conditions (n = 8) or during a euglycemic insulin infusion at 30 mU/min per m(2) (n = 8). PET images were coregistered with magnetic resonance imaging to contrast glucose kinetics in soleus, a highly oxidative muscle, with tibialis anterior, a less oxidative muscle. During fasting conditions, uptake of [(11)C]3-OMG was similar in soleus and tibialis anterior muscles, despite higher delivery to soleus (by 35%; P < 0.01). Uptake of [(18)F]FDG was also similar between muscle during fasting, and glucose transport was found to be the dominant locus of control (90%) for glucose uptake under this condition. Insulin increased uptake of [(11)C]3-OMG substantially and strongly stimulated the kinetics of bidirectional glucose transport. Uptake of [(11)C]3-OMG was higher in soleus than tibialis anterior muscle (by 22%; P < 0.01), a difference partially due to higher delivery, which was again found to be 35% higher to soleus (P < 0.01). The uptake of [(18)F]FDG was 65% greater in soleus compared with tibialis anterior muscle, a larger difference than for [(11)C]3-OMG (P < 0.01), indicating an added importance of glucose phosphorylation in defining insulin sensitivity. Analysis of the distribution of control during insulin-stimulated conditions revealed that most of the control was posited at delivery and transport and was equally divided between these steps. Thus, insulin evokes a broader distribution of control than during fasting conditions in governing glucose uptake into skeletal muscle. This redistribution of control is triggered by the robust stimulation of glucose transport, which in turn unmasks a greater dependence upon delivery and glucose phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17065339     DOI: 10.2337/db06-0762

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  21 in total

1.  Dynamic PET imaging reveals heterogeneity of skeletal muscle insulin resistance.

Authors:  Jason M Ng; Alessandra Bertoldo; Davneet S Minhas; Nicole L Helbling; Paul M Coen; Julie C Price; Claudio Cobelli; David E Kelley; Bret H Goodpaster
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

2.  A new Michaelis-Menten-based kinetic model for transport and phosphorylation of glucose and its analogs in skeletal muscle.

Authors:  Hsuan-Ming Huang; Faramarz Ismail-Beigi; Raymond F Muzic
Journal:  Med Phys       Date:  2011-08       Impact factor: 4.071

3.  Effect of blood glucose level on standardized uptake value (SUV) in 18F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements.

Authors:  Mahsa Eskian; Abass Alavi; MirHojjat Khorasanizadeh; Benjamin L Viglianti; Hans Jacobsson; Tara D Barwick; Alipasha Meysamie; Sun K Yi; Shingo Iwano; Bohdan Bybel; Federico Caobelli; Filippo Lococo; Joaquim Gea; Antonio Sancho-Muñoz; Jukka Schildt; Ebru Tatcı; Constantin Lapa; Georgia Keramida; Michael Peters; Raef R Boktor; Joemon John; Alexander G Pitman; Tomasz Mazurek; Nima Rezaei
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-22       Impact factor: 9.236

Review 4.  Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature.

Authors:  Eugene J Barrett; Hong Wang; Charles T Upchurch; Zhenqi Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-24       Impact factor: 4.310

Review 5.  Diagnostic imaging in the management of patients with metabolic syndrome.

Authors:  Seo Rin Kim; Lilach O Lerman
Journal:  Transl Res       Date:  2017-11-22       Impact factor: 7.012

6.  Dexamethasone-induced insulin resistance: kinetic modeling using novel PET radiopharmaceutical 6-deoxy-6-[(18)F]fluoro-D-glucose.

Authors:  Kuan-Hao Su; Visvanathan Chandramouli; Faramarz Ismail-Beigi; Raymond F Muzic
Journal:  Mol Imaging Biol       Date:  2014-10       Impact factor: 3.488

7.  In vivo PET imaging with [(18)F]FDG to explain improved glucose uptake in an apolipoprotein A-I treated mouse model of diabetes.

Authors:  Blake J Cochran; William J Ryder; Arvind Parmar; Shudi Tang; Anthonin Reilhac; Andrew Arthur; Arnaud Charil; Hasar Hamze; Philip J Barter; Leonard Kritharides; Steven R Meikle; Marie-Claude Gregoire; Kerry-Anne Rye
Journal:  Diabetologia       Date:  2016-05-18       Impact factor: 10.122

8.  Uptake of 18F-labeled 6-fluoro-6-deoxy-D-glucose by skeletal muscle is responsive to insulin stimulation.

Authors:  Chandra Spring-Robinson; Visvanathan Chandramouli; William C Schumann; Peter F Faulhaber; Yanming Wang; Chunying Wu; Faramarz Ismail-Beigi; Raymond F Muzic
Journal:  J Nucl Med       Date:  2009-05-14       Impact factor: 10.057

Review 9.  Sugar flux through the flight muscles of hovering vertebrate nectarivores: a review.

Authors:  Kenneth C Welch; Chris C W Chen
Journal:  J Comp Physiol B       Date:  2014-07-17       Impact factor: 2.200

Review 10.  Sarcopenia: etiology, clinical consequences, intervention, and assessment.

Authors:  T Lang; T Streeper; P Cawthon; K Baldwin; D R Taaffe; T B Harris
Journal:  Osteoporos Int       Date:  2009-09-25       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.